Clinical Trial Update: Study of Pexidartinib in Participants With Moderate Hepatic Impairment Compared With Healthy Participants [EARLY_Phase 1]

View source ↗

Summary

Early-phase clinical trial comparing pexidartinib pharmacokinetics and safety in participants with moderate hepatic impairment versus healthy participants has b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Impairment

Drugs mentioned

• Pexidartinib (pexidartinib)

Snippet

Sponsor: Daiichi Sankyo | Conditions: Moderate Hepatic Impairment | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2021-06-07